Neuromuscular Symptoms and Elevated Creatine Kinase After Statin Withdrawal
NEJM 362:564-565, Echaniz-Laguna,A.,et al, 2010
The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005
Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998
Prevalence of Cannabis Withdrawal Symptoms Among People with Regular or Dependent Use of Cannabinoids
JAMA doi:10.1001/JAMANETWORKOPEN.2020.2370, Bahji, A.,et al, 2020
Neonatal Abstinence Syndrome
JAMA 319:1362-1374, Wachman, E.,et al, 2018
Recognition and Management of Withdrawal Delirium
NEJM 371:2109-2113, Schuckit, M.A., 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Opiates and Synthetic Analgesic Drugs
Adams & Victors Principles of Neurology Chp 43, pg 1201, Ropper, A.H.,et al, 2014
"Bath Salts" Intoxication
NEJM 365:967-968, Ross, E.A.,et al, 2011
Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006
Discontinuing Antiepileptic Drugs in Children with Epilepsy
NEJM 330:1407-1410, Tennison,M.,et al, 1994
Chronic Daily Headache
Neurol 42:32-36, Sheftell,F.D., 1992
Risk Associated with Heparin Withdrawal in Ischaemic Cerebrovascular Disease
JNNP 52:1332-1336, Slivka,A.,et al, 1989
Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012
Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008
Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003
Easy Therapeutical Management of Sumatriptan-Induced Daily Headache
Neurol 47:297-298, Gobel,H.,et al, 1996
Use of Benzodiazepines in Anxiety Disorders
NEJM 328:1398-1405, Shader,R.I.&Greenblatt,D.J., 1993
Abrupt Outpatient Withdrawal of Medication in Analgesic-Abusing Migraineurs
Lancet 337:1442-1443, Hering,T.&Steiner,T.J., 1991